Abstract
Development of type 2 diabetes mellitus (T2DM) is a result of the combination of insulin resistance and relative, and later on absolute, deficiency of insulin secretion. This is why insulin therapy represents integral part of T2DM treatment armamentarium.
Nevertheless, insulin therapy is often associated with numerous prejudices on part of both some patients and some physicians, which leads to its late initiation with subsequent non-satisfactory compensation in patients with a longer history of 2TDM.